Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
01/07/2024 | 13:59 | Edgar (US Regulatory) | Form DEF 14C - Other definitive information statements | NASDAQ:NMRD | Nemaura Medical Inc |
01/07/2024 | 13:00 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | NASDAQ:NMRD | Nemaura Medical Inc |
17/05/2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NMRD | Nemaura Medical Inc |
19/04/2024 | 22:05 | Edgar (US Regulatory) | Form PRE 14C - Other preliminary information statements | NASDAQ:NMRD | Nemaura Medical Inc |
22/01/2024 | 22:15 | GlobeNewswire Inc. | Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET | NASDAQ:NMRD | Nemaura Medical Inc |
17/01/2024 | 23:17 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:NMRD | Nemaura Medical Inc |
17/01/2024 | 23:15 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:NMRD | Nemaura Medical Inc |
09/01/2024 | 23:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NMRD | Nemaura Medical Inc |
09/01/2024 | 23:29 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:NMRD | Nemaura Medical Inc |
03/01/2024 | 13:00 | GlobeNewswire Inc. | Important Update on Listing Status and Strategic Direction | NASDAQ:NMRD | Nemaura Medical Inc |
13/12/2023 | 14:00 | GlobeNewswire Inc. | Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision | NASDAQ:NMRD | Nemaura Medical Inc |
07/12/2023 | 16:46 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | NASDAQ:NMRD | Nemaura Medical Inc |
21/11/2023 | 14:30 | GlobeNewswire Inc. | Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth | NASDAQ:NMRD | Nemaura Medical Inc |
14/11/2023 | 14:00 | GlobeNewswire Inc. | Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs | NASDAQ:NMRD | Nemaura Medical Inc |
13/11/2023 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:NMRD | Nemaura Medical Inc |
13/11/2023 | 22:14 | GlobeNewswire Inc. | Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update | NASDAQ:NMRD | Nemaura Medical Inc |
26/09/2023 | 15:50 | GlobeNewswire Inc. | Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs. | NASDAQ:NMRD | Nemaura Medical Inc |
22/09/2023 | 21:05 | GlobeNewswire Inc. | Maxim Group LLC to Host the Virtual Tech Conference Series: Emerging Growth in A.I., on Tuesday, September 26th & Wednesday, September 27th at 8:00 A.M. ET. | NASDAQ:NMRD | Nemaura Medical Inc |
18/09/2023 | 15:15 | GlobeNewswire Inc. | Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference | NASDAQ:NMRD | Nemaura Medical Inc |
14/09/2023 | 14:00 | GlobeNewswire Inc. | Nemaura Medical Provides Update on Nasdaq Compliance Status and Process | NASDAQ:NMRD | Nemaura Medical Inc |
13/09/2023 | 14:00 | GlobeNewswire Inc. | Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program | NASDAQ:NMRD | Nemaura Medical Inc |
12/09/2023 | 15:26 | GlobeNewswire Inc. | Nemaura Medical Announces Participation at HLTH 2023, Las Vegas | NASDAQ:NMRD | Nemaura Medical Inc |
11/09/2023 | 22:41 | Edgar (US Regulatory) | Form 424B8 - Prospectus filed pursuant to Rule 424(b)(8) | NASDAQ:NMRD | Nemaura Medical Inc |
17/08/2023 | 14:30 | GlobeNewswire Inc. | Nemaura Medical Announces SFDA Approval of sugarBEAT® | NASDAQ:NMRD | Nemaura Medical Inc |
14/08/2023 | 14:30 | GlobeNewswire Inc. | Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update | NASDAQ:NMRD | Nemaura Medical Inc |
11/08/2023 | 22:05 | GlobeNewswire Inc. | Nemaura Medical Secures $6.5m in Non-Dilutive Funding | NASDAQ:NMRD | Nemaura Medical Inc |
08/08/2023 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:NMRD | Nemaura Medical Inc |
03/08/2023 | 22:08 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:NMRD | Nemaura Medical Inc |
17/07/2023 | 15:30 | Edgar (US Regulatory) | Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] | NASDAQ:NMRD | Nemaura Medical Inc |
14/07/2023 | 15:25 | GlobeNewswire Inc. | Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023 | NASDAQ:NMRD | Nemaura Medical Inc |